GABAA receptor subtypes: Dissecting their pharmacological functions

Uwe Rudolph; Florence Crestani; Hanns Möhler

doi:10.1016/S0165-6147(00)01646-1

GABA_A receptor subtypes: Dissecting their pharmacological functions

Uwe Rudolph, Florence Crestani, Hanns Möhler

Research output: Contribution to journal › Review article › peer-review

Abstract

The enhancement of GABA-mediated synaptic transmission underlies the pharmacotherapy of various neurological and psychiatric disorders. GABA_A receptors are pluripotent drug targets that display an extraordinary structural heterogeneity: they are assembled from a repertoire of at least 18 subunits (α1-6, β1-3, γ1-3, δ, ε, θ, ρ1-3). However, differentiating defined GABA_A receptor subtypes on the basis of function has had to await recent progress in the genetic dissection of receptor subtypes in vivo. Evidence that the various actions of allosteric modulators of GABA_A receptors, in particular the benzodiazepines, can be attributed to specific GABA_A receptor subtypes will be discussed. Such discoveries could open up new avenues for drug development.

Original language	English (US)
Pages (from-to)	188-194
Number of pages	7
Journal	Trends in Pharmacological Sciences
Volume	22
Issue number	4
DOIs	https://doi.org/10.1016/S0165-6147(00)01646-1
State	Published - Apr 1 2001
Externally published	Yes

ASJC Scopus subject areas

Toxicology
Pharmacology

Online availability

10.1016/S0165-6147(00)01646-1

Library availability

Discover UIUC Full Text

Cite this

@article{2ae794298b2343ee9ed3441063131467,

title = "GABAA receptor subtypes: Dissecting their pharmacological functions",

abstract = "The enhancement of GABA-mediated synaptic transmission underlies the pharmacotherapy of various neurological and psychiatric disorders. GABAA receptors are pluripotent drug targets that display an extraordinary structural heterogeneity: they are assembled from a repertoire of at least 18 subunits (α1-6, β1-3, γ1-3, δ, ε, θ, ρ1-3). However, differentiating defined GABAA receptor subtypes on the basis of function has had to await recent progress in the genetic dissection of receptor subtypes in vivo. Evidence that the various actions of allosteric modulators of GABAA receptors, in particular the benzodiazepines, can be attributed to specific GABAA receptor subtypes will be discussed. Such discoveries could open up new avenues for drug development.",

author = "Uwe Rudolph and Florence Crestani and Hanns M{\"o}hler",

year = "2001",

month = apr,

day = "1",

doi = "10.1016/S0165-6147(00)01646-1",

language = "English (US)",

volume = "22",

pages = "188--194",

journal = "Trends in Pharmacological Sciences",

issn = "0165-6147",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - GABAA receptor subtypes

T2 - Dissecting their pharmacological functions

AU - Rudolph, Uwe

AU - Crestani, Florence

AU - Möhler, Hanns

PY - 2001/4/1

Y1 - 2001/4/1

N2 - The enhancement of GABA-mediated synaptic transmission underlies the pharmacotherapy of various neurological and psychiatric disorders. GABAA receptors are pluripotent drug targets that display an extraordinary structural heterogeneity: they are assembled from a repertoire of at least 18 subunits (α1-6, β1-3, γ1-3, δ, ε, θ, ρ1-3). However, differentiating defined GABAA receptor subtypes on the basis of function has had to await recent progress in the genetic dissection of receptor subtypes in vivo. Evidence that the various actions of allosteric modulators of GABAA receptors, in particular the benzodiazepines, can be attributed to specific GABAA receptor subtypes will be discussed. Such discoveries could open up new avenues for drug development.

AB - The enhancement of GABA-mediated synaptic transmission underlies the pharmacotherapy of various neurological and psychiatric disorders. GABAA receptors are pluripotent drug targets that display an extraordinary structural heterogeneity: they are assembled from a repertoire of at least 18 subunits (α1-6, β1-3, γ1-3, δ, ε, θ, ρ1-3). However, differentiating defined GABAA receptor subtypes on the basis of function has had to await recent progress in the genetic dissection of receptor subtypes in vivo. Evidence that the various actions of allosteric modulators of GABAA receptors, in particular the benzodiazepines, can be attributed to specific GABAA receptor subtypes will be discussed. Such discoveries could open up new avenues for drug development.

UR - http://www.scopus.com/inward/record.url?scp=0035313382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035313382&partnerID=8YFLogxK

U2 - 10.1016/S0165-6147(00)01646-1

DO - 10.1016/S0165-6147(00)01646-1

M3 - Review article

C2 - 11282419

AN - SCOPUS:0035313382

SN - 0165-6147

VL - 22

SP - 188

EP - 194

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

IS - 4

ER -